Synergistic bacterial compositions and methods of production and use thereof

US9533014B2 · kind B2 · utility

Assignee

• Seres Therapeutics, Inc. · US

Inventors

• Matthew R. Henn · Somerville, US
• Geoffrey von Maltzahn · Boston, US
• Anthony Mario D'Onofrio · Northborough, US
• Kevin Daniel Litcofsky · Boston, US
• David Arthur Berry · Brookline, US
• David N. Cook · Lafayette, US
• Noubar B. Afeyan · Lexington, US
• John Grant Aunins · Cambridge, US

Key dates

• Filing date: Jan 8, 2015
• Grant date: Jan 3, 2017
• Expiry date: Jan 8, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.